Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Jun 01, 2021 5:10pm
109 Views
Post# 33307733

RE:Voting results

RE:Voting results
Nominee Votes for Votes withheld % of votes cast  
      FOR WITHELD  
Glenn Rourke 13,258,835 11,591,778 53.35% 46.65%  
Donald J. Oborowsky 13,411,266 11,439,347 53.97% 46.03%  
John Zupancic 21,174,572 3,676,041 85.21% 14.79%  
Gilles Gagnon 20,098,767 4,751,846 80.88% 19.12%  
Dr. William Li 21,576,317 3,274,296 86.82% 13.18%  
Dr. Ulrich Kosciessa 23,611,800 1,238,813 95.01% 4.99%  

All other matters at the Shareholders' meeting, namely the appointment of auditors and the re-approval and ratification of the Company’s Stock Option Plan, as proposed in the Company’s information circular dated April 7, 2021, were also approved by shareholders.

Telling results nonetheless...

User2020 wrote: Two directors almost got voted out. 


<< Previous
Bullboard Posts
Next >>